Login | EN Navigation Facts and Figures R&D at a glance The owners of Grünenthal are highly committed to R&D: as part of our long-term strategy we are striving to increase the number of projects in each development phase and to increase our core R&D investments up to a level of 400 mn € in the next decade. 1 R&D Unit in Aachen, Germany (Headquarters) with branches in the U.S. and Latin America > 40 We have more than 40 years experience in the pain area and beyond ~ 190 Our 2016 R&D budget to invest into new projects and to maintain our infrastructure is about 190 mn € ~ 700 About 700 FTEs drive all aspects of the R&D value chain ~ 750 750 mn € (estimated) worldwide cumulative revenues as output from our R&D engine in 2016 More about Innovation Focus Areas Pain, Specialty Therapeutics, Devices & Technologies Continue... Innovation Capabilities Grünenthal Innovation is a fully integrated, capable and agile R&D organization. Through our networked approach, we interlink and supplement our R&D expertise with external knowledge. Continue... Partnering & Collaborations We have extensive experience with co-development, partnering and outsourcing of activities at all stages. Continue... Our Pipeline Grünenthal has an exciting R&D pipeline with several new drug candidates in different phases of development. Continue... You are here: Home // Innovation // Facts and Figures Overview Company Corporate Executive Board Supervisory Board Facts & Figures Compliance Sustainability Social Responsibility Initiatives History Production Sites Affiliates worldwide Memberships Products Innovation Focus Areas Facts and Figures Innovation Capabilities Partnering & Collaborations Our Pipeline Patients Patient Summit Understanding Pain Definition of Pain Pain Management Grünenthal's Press Centre News Downloads Contact Partnering Our Partnering Model Areas of Interest Contact Jobs & Career Service Contact Grünenthal Worldwide America Europe Grünenthal 2021 © Imprint Privacy Statement Disclaimer General Terms and Conditions